Regioselectivity Inversion in the Cycloaddition Reaction between Stable Nitrile Oxides and Acylalkyne Derivatives
Chemical and Pharmaceutical Bulletin · 2025
DOI: 10.1248/cpb.c25-00471 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2025. Verfasst von Yuki Maeda und 6 weiteren Autor:innen. Beteiligte Einrichtung: Showa Pharmaceutical University, 3-2-1 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan. Hauptthemen laut MEDLINE: Nitriles, Oxides, Alkynes, Isoxazoles. Die Arbeit nennt 75 Literaturangaben.
Abstract (Originalsprache)
1,3-Dipolar cycloaddition reaction of stable nitrile oxides with α,β-alkynyl hydrazones affords 5-iminoisoxazoles, whereas the reaction of nitrile oxides with α,β-alkynyl carbonyl compounds gives 4-acylisoxazoles. The regioselectivity of the cycloaddition reaction is reversed due to the electron-donating character of the hydrazone group. The 5-iminoisoxazoles are readily converted to the corresponding 4-acylisoxazoles by dehydrazonation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Showa Pharmaceutical University, 3-2-1 Higashi-Tamagawagakuen, Machida, Tokyo 194-8543, Japan.
Zitieren
APA
Maeda, Y., Hashimoto, Y., Aoki, R., Kimura, N., Tanaka Iii, K., Tamura, O., & Morita, N. (2025). Regioselectivity Inversion in the Cycloaddition Reaction between Stable Nitrile Oxides and Acylalkyne Derivatives. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c25-00471
Vancouver
Maeda Y, Hashimoto Y, Aoki R, Kimura N, Tanaka Iii K, Tamura O, et al. Regioselectivity Inversion in the Cycloaddition Reaction between Stable Nitrile Oxides and Acylalkyne Derivatives. Chemical and Pharmaceutical Bulletin. 2025. doi:10.1248/cpb.c25-00471
BibTeX
@article{Maeda2025,
author = {Maeda, Yuki and Hashimoto, Yoshimitsu and Aoki, Ryo and Kimura, Nozomi and Tanaka Iii, Kosaku and Tamura, Osamu and Morita, Nobuyoshi},
title = {Regioselectivity Inversion in the Cycloaddition Reaction between Stable Nitrile Oxides and Acylalkyne Derivatives},
journal = {Chemical and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/cpb.c25-00471}
}
EUVIMED